Arizona's Department of Transportation is currently reviewing Tesla's (NASDAQ: TSLA) application to operate autonomous vehicles both with and without a driver, with a decision now expected by the end of August.
Is It Time to Ditch VOO and SPY? Why Betting on the S&P 500 Is Too Risky Today — Negative
SPY VOO 24/7 Wall Street — August 11, 2025Key Points in This Article: The S&P 500's historical 10% annual returns have made Vanguard S&P 500 ETF (VOO) and State Street's SPDR S&P 500 ETF Trust (SPY) go-to choices for passive investors.
Worried About a Fading Rally? Consider These 3 Dividend Stocks — Negative
CINF JNJ TROW MarketBeat — August 11, 2025Investors have checked plenty of boxes off their 2021 market bingo cards lately: a V-shaped recovery in the S&P 500 after a quick bear market, a wild cryptocurrency rally, and beaten-down meme stocks generating short squeezes.
Advanced Micro's Mixed Earnings Results Add Fuel To Direxion's AMD-Focused Bull And Bear Funds — Neutral
AMD Benzinga — August 11, 2025Amid growing concerns about economic stability and the implementation of President Donald Trump's trade tariffs, investors have been anxious this earnings season. Case in point is semiconductor giant Advanced Micro Devices Inc. AMD, which recently disclosed a mixed performance for its financial disclosure.
RXO, Inc. (NYSE:RXO ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Drew M. Wilkerson - Chairman & CEO James E.
Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial — Neutral
QNTM GlobeNewsWire — August 11, 2025TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to innovative therapies for neurodegenerative disorders, today announces through its subsidiary, Huge Biopharma Australia Pty Ltd., that it has signed an agreement with a leading contract development and manufacturing organization (CDMO) to manufacture an oral drug formulation of Lucid-MS. The oral formulation of Lucid-MS will serve as the drug product for the Company's Phase 2 clinical trial, which will test the efficacy on humans of Lucid-MS as a possible treatment for people to …
Valvoline has delivered steady revenue and profit growth, expanding its store count and maintaining strong same-store sales in a maturing industry. Despite solid fundamentals, share price performance has lagged the S&P 500, leading me to revise my previous 'strong buy' rating to a soft 'buy.' Valuation is attractive relative to peers, with Valvoline trading at the lowest price-to-earnings ratio among comparable companies.
Upstart Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes Due 2032 — Neutral
UPST Business Wire — August 11, 2025SAN MATEO, Calif.--(BUSINESS WIRE)--Upstart Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes Due 2032.
Vacation Reading: A Look at July's Most Popular ETF Content — Neutral
AMLP CSHI FHEQ QQQ VWOB ETF Trends — August 11, 2025I hope you enjoyed a great July, whether you were on vacation or not. I've been catching up on the fantastic content our team at ETF Trends and ETF Database produced in July 2025.
Not all companies need to grow rapidly to see success; periods of optimization are essential. Get paid monthly from experiential properties. Your retirement portfolio can pay for your retirement, one dividend at a time.
Caledonia Mining: Broker hails record second quarter as it upgrades valuation — Positive
CMCL Proactive Investors — August 11, 2025Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) delivered an exceptional second quarter, setting new records for production, profitability, and cash generation at its flagship Blanket Mine in Zimbabwe. The results, released earlier on Monday, show the company firing on all cylinders amid soaring gold prices, with Cavendish Capital Markets highlighting that second-quarter profitability actually exceeded entire full-year profits from recent years.
Kelly Services, Inc. (KELYA) Q2 2025 Earnings Call Transcript — Neutral
KELYA KELYB Seeking Alpha — August 11, 2025Kelly Services, Inc. (NASDAQ:KELYA ) Q2 2025 Earnings Conference Call August 7, 2025 9:00 AM ET Company Participants Peter W. Quigley - President, CEO & Director Scott Thomas - Corporate Participant Troy R.
Rail Vision Receives European Patent for Innovative Locomotive Imaging Technology — Neutral
RVSN GlobeNewsWire — August 11, 2025Ra'anana, Israel, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today announced that the European Patent Office has issued a Decision to Grant for the Company's patent application covering a novel system designed to significantly enhance the sampling rate of an imager detector for a Selected Region Of Interest (SROI).
CHICAGO , Aug. 11, 2025 /PRNewswire/ -- On August 1, 2025, United States Cellular Corporation changed its name to Array Digital Infrastructure, Inc.SM (ArraySM) As previously announced, Array will hold a teleconference on August 11, 2025, at 9:00 a.m. CDT. Listen to the call live via the Events & Presentations page of investors.arrayinc.com or investors.tdsinc.com.
Nayax Announces Strategic Partnership with Leading Global EVSE Provider Autel Energy to Deliver Embedded Payment Solutions — Neutral
NYAX GlobeNewsWire — August 11, 2025HERZLIYA, Israel, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by simplifying payments and maximizing loyalty , today announced a strategic partnership to provide embedded payment solutions for Autel Energy, a trusted pioneer in electric vehicle (EV) charging technology with a growing footprint across 35 major markets in North America and Europe.
I'd Load Up On These 5%-9% Yielders If I Had The Cash — Neutral
ARIS OKE WES Seeking Alpha — August 11, 2025The market's gains come from a tiny group of stocks. Owning the S&P 500 is safe, but boring. I prefer hunting overlooked winners. The S&P 500's dominance hides growing concentration risks. While Big Tech thrives on momentum, I prefer hunting in overlooked corners of the market, where strong fundamentals meet unjustified skepticism. My latest finds combine high yield, resilient cash flows, and secular tailwinds. Proof that you don't need to chase the crowd for quality.
ReElement Technologies Produces Greater than 99.9% Pure Separated Germanium — Neutral
AREC Accesswire — August 11, 2025Successfully achieves high-purity germanium from recycled material and ore-based feedstock through internally developed flow sheet Targeting defense and advanced industrial partners requiring 99.9%-99.999% purity, sourced from virgin supply or customer-provided recycled feedstock Multi-mineral, multi-feedstock refining platform continues to set global benchmarks for versatility and efficiency FISHERS, IN / ACCESS Newswire / August 11, 2025 / American Resources Corporation's (NASDAQ:AREC) ("American Resources") through its holding in ReElement Technologies Corporation ("ReElement" or "RTC"), a leading U.S. innovator in rare earth element (REE) and critical mineral refining, today announced it has successfully developed commercial protocols to produce ultra-high-purity germanium from both recycled and …
Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules — Neutral
ENTO Newsfile Corp — August 11, 2025Boca Raton, Florida--(Newsfile Corp. - August 11, 2025) - Entero Therapeutics, Inc. (NASDAQ: ENTO) (the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of approximately $3 million of pre-funded and common warrants. The entire transaction has been priced at the market under Nasdaq rules.
Altimmune Board of Directors Appoints Jerry Durso as Chairman — Neutral
ALT GlobeNewsWire — August 11, 2025Appointment recognizes Mr. Durso's extensive commercial expertise as Altimmune prepares for Phase 3 development of pemvidutide in MASH
Aramark Collegiate Hospitality Meets Student Tastes for Unique Campus Experiences — Neutral
ARMK Business Wire — August 11, 2025PHILADELPHIA--(BUSINESS WIRE)--As the 2025–2026 school year begins, Aramark Collegiate Hospitality is responding to today's campus needs by listening closely and taking thoughtful action to align with each university's unique culture. From tailored food options to updated meal plans, Aramark shows that campus dining is about more than just meals—it's about building connection, community, and belonging. “Students are telling us what matters to them, and we're responding in real time,” said Jack.